18.11.2014 • NewsGE HealthcareLife Sciences

GE Healthcare Life Sciences With New Istanbul Center

GE Healthcare Life Sciences, will open a technology and training laboratory in Istanbul next year to support Turkey's expanding biopharmaceutical and biotechnology industry.

The facility, complementing GE's global network of customer training and technology facilities in the US, UK, China, India and Sweden, will be part of the company's Turkey Innovation Center. It will offer advanced technical training and technology evaluation to the local biopharmaceutical sector, as well as being open to universities as a location for elements of biotechnology degree courses.

Academics, pharmaceutical and biotechnology researchers as well as GE customers from the Middle East and Russia will also have access to the laboratory for small scale research studies.

Turkey plans to expedite the transformation of its healthcare sector through domestic manufacturing of both devices and pharmaceuticals. The country's goal is for local manufacturing to represent 60% of its pharmaceuticals consumption.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.